Outcomes of intravascular brachytherapy for recurrent drug‐eluting in‐stent restenosis
Michael Megaly(St. John Medical Center), Emmanouil S. Brilakis(Minneapolis Heart Institute Foundation), Santiago García(Minneapolis VA Health Care System), Matthew Glogoza(Abbott Northwestern Hospital), Jay H. Traverse(Abbott Northwestern Hospital), Anil Poulose(Abbott Northwestern Hospital), Ilias Nikolakopoulos(University of California, San Francisco), Evangelia Vemmou(Abbott Northwestern Hospital), Larissa Stanberry(Abbott Northwestern Hospital), Patsa Sullivan(Abbott Northwestern Hospital), M. Mooney(Fermi National Accelerator Laboratory), Laura Willson(Abbott Northwestern Hospital), Paul Sorajja(Abbott Northwestern Hospital), Iosif Xenogiannis(Hippocration General Hospital), Yale Wang(Abbott Northwestern Hospital), Martin Burke(Abbott Northwestern Hospital), David J. Monyak(Abbott Northwestern Hospital), Ivan Chavez(Abbott Northwestern Hospital)
Cited by 23
Related Papers
Intramyocardial Transplantation of Autologous CD34 <sup>+</sup> Stem Cells for Intractable Angina
|Circulation|2007|557
Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention
|Circulation|2019|433
Outcomes After Complete Versus Incomplete Revascularization of Patients With Multivessel Coronary Artery Disease
|Journal of the American College of Cardiology|2013|389
Temporal Trends and Outcomes of Mechanical Complications in Patients With Acute Myocardial Infarction
|JACC: Cardiovascular Interventions|2019|374
Global Chronic Total Occlusion Crossing Algorithm
|Journal of the American College of Cardiology|2021|229